succinic acid and tobramycin

succinic acid has been researched along with tobramycin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Bahamondez-Canas, TF; Ferrati, S; Moraga-Espinoza, DF; Smyth, HDC	1

Other Studies

2 other study(ies) available for succinic acid and tobramycin

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Development, Characterization, and In Vitro Testing of Co-Delivered Antimicrobial Dry Powder Formulation for the Treatment of Pseudomonas aeruginosa Biofilms. Journal of pharmaceutical sciences, 2018, Volume: 107, Issue:8 Topics: Administration, Inhalation; Alanine; Anti-Bacterial Agents; Biofilms; Desiccation; Drug Compounding; Dry Powder Inhalers; Excipients; Humans; Particle Size; Powders; Proline; Pseudomonas aeruginosa; Pseudomonas Infections; Succinic Acid; Tobramycin	2018

Article

Year

Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.

Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

Topics:

2008

Development, Characterization, and In Vitro Testing of Co-Delivered Antimicrobial Dry Powder Formulation for the Treatment of Pseudomonas aeruginosa Biofilms.

Journal of pharmaceutical sciences, 2018, Volume: 107, Issue:8

Topics: Administration, Inhalation; Alanine; Anti-Bacterial Agents; Biofilms; Desiccation; Drug Compounding; Dry Powder Inhalers; Excipients; Humans; Particle Size; Powders; Proline; Pseudomonas aeruginosa; Pseudomonas Infections; Succinic Acid; Tobramycin

2018